Home›Companies
Companies
Companies
Companies, labs and communities building AI.
Total 11 · Clear filters
| Baichuan Intelligence Baichuan Intelligence (百川智能) is a Beijing AI company founded in April 2023 by Wang Xiaochuan. It released open-source language models from 2023 and later focused on applying AI to healthcare. | 2023 |
| Broad Institute An independent, non-profit research institute in Cambridge, Massachusetts, founded in 2004 with support from Eli and Edythe Broad, working to understand the roots of disease and turn biological insights into impact for patients. | 2004 |
| EvolutionaryScale A public benefit AI company that introduced itself alongside its ESM3 model in June 2024 and whose team joined Biohub in November 2025. | 2024 |
| Exscientia An AI drug-discovery company with sites in London and Oxford that focused on computational molecule design; in November 2024 it became a wholly-owned subsidiary of Recursion, with a combined pipeline of more than 10 clinical and preclinical programmes. | |
| Fourier Intelligence Fourier is a Shanghai robotics company founded in 2015 by Gu Jie. It began with rehabilitation robots and exoskeletons, then released the GR-1, GR-2 and GR-3 full-size humanoid robots in 2023, 2024 and 2025. | 2015 |
| Howard Hughes Medical Institute HHMI is a private biomedical research institution founded in 1953 that funds scientists at all career stages and runs the Janelia Research Campus. | 1953 |
| Insilico Medicine Insilico Medicine is a drug discovery company founded in the United States in 2014 that pairs an AI software platform, Pharma.AI, with its own pipeline of drug programmes and automated laboratory work. | 2014 |
| Institute for Protein Design A research institute at the University of Washington, founded in 2012 and led by David Baker, that designs new proteins for medicine and technology; its labs produced RoseTTAFold and, it says, the first computationally designed vaccine. | 2012 |
| Isomorphic Labs Isomorphic Labs is an AI drug discovery company launched out of DeepMind and dated to 2021, building the IsoDDE platform and working with Novartis, Eli Lilly and Johnson & Johnson. | 2021 |
| Keya Medical Chinese medical-AI company founded in 2016 that focuses on AI for diagnosing and treating coronary heart disease, and says it holds China's first class III AI medical device certificate. | 2016 |
| Recursion Recursion is a drug discovery company that pairs automated laboratory experiments with computation; its Recursion OS platform spans target identification to clinical trial enrolment. It listed on Nasdaq in 2021 and combined with Exscientia in 2024. | 2013 |